DIAREG - Landstinget Sörmland
DIAREG - Landstinget Sörmland
DIAREG - Landstinget Sörmland
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Nätverket <strong>DIAREG</strong><br />
19. Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D. Metformin monotherapy for<br />
type 2 diabetes mellitus. Cochrane Database Syst Rev 2005(3):CD002966.<br />
20. Salpeter SR, Greyber E, Pasternak GA, Salpeter Posthumous EE. Risk of fatal and nonfatal lactic<br />
acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev 2010(1):<br />
CD002967.<br />
21. Brophy S et al. Interventions for latent autoimmune diabetes (LADA) in adults (Review).<br />
Cochrane Database of Systematic Reviews 2007. Art nr CD 006165.<br />
22. Eurich DT et al. Benefits and harms of antidiabetic agents in patients with diabetes and heart failure:<br />
systematic review. BMJ 2007;335(7618):497.<br />
23. http://www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf<br />
24. Van de Laar FA, Lucassen PL, Akkermans RP, Van de Lisdonk EH, Rutten GE, Van Weel C. Alphaglucosidase<br />
inhibitors for type 2 diabetes mellitus. Cochrane Database Syst Rev 2005(2):CD003639.<br />
25. Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for type 2 diabetes<br />
mellitus. Cochrane Database Syst Rev 2006(4):CD006060.<br />
26. Elrick H, Stimmler L, Hlad CJ Jr et al. Plasma insulin response to oral and intravenous glucose<br />
administration. J Clin Endocrinol Metab 1964;24:1076-1082.<br />
27. Holst JJ, Vilsböll T, and Deacon CF. The incretin system and its role in type 2 diabetes. Molecular and<br />
Cellular Endocrinology 2009;297:127-136.<br />
28. Nauck M, Stockmann F, Ebert R, Creutfeldt W. Reduced incretin effect in type 2 (non-insulin dependent)<br />
diabetes. Diabetologia 1986;29:46-52.<br />
29. Peters, A. Incretin-Based Therapies: Review of Current Clinical Trial Data The American Journal of<br />
Medicine 2010;123:S28-S37.<br />
30. Lovshin JA & Drucker DJ. Incretin-based therapies for type 2 diabetes mellitus. Nat Rev Endocrinol<br />
2009;5:262-269.<br />
31. Buse J, Rosenstock J, Sesti G et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes:<br />
a 26-week randomised, parallel-group, multinational, open-label trial. Lancet 2009;374:39–47.<br />
32. http://www.nice.org.uk/nicemedia/pdf/CG87NICEGuideline.pdf<br />
33. http://www2.cochrane.org/reviews/en/ab006739.html<br />
34. Black, C, Donnelly, P, McIntyre, L, Royle, PL, Shepherd, JP, Thomas, S. Meglitinide analogues for type<br />
2 diabetes mellitus. Cochrane Database Syst Rev. 2007; (2):CD004654.<br />
Diabetesläkemedel Referenser Fastställt 2011-05-31<br />
24
Change language